Blood glucose testing in the hospital: Error sources and risk management

Journal of Diabetes Science and Technology

Volumn 5, Issue 1, 2011, Pages 173-177

  Nichols, James H ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYSTATE HEALTH   (United States)

Author keywords

Errors; Glucose monitor; Glucose test; Risk management

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CLINICAL LABORATORY; DATA ANALYSIS SOFTWARE; DISINFECTION; ENVIRONMENTAL EXPOSURE; EQUIPMENT FAILURE; HUMAN; HYPOGLYCEMIA; INFORMATION PROCESSING; LABORATORY AUTOMATION; LABORATORY TEST; MEDICAL ERROR; OPERATOR; REVIEW; RISK MANAGEMENT; RISK REDUCTION; STAFF TRAINING; TEST STRIP; DIAGNOSIS, MEASUREMENT AND ANALYSIS; EVALUATION; GLUCOSE BLOOD LEVEL; HOSPITAL; MEDICAL STAFF; METHODOLOGY; MONITORING; PATIENT; STANDARD;

BLOOD GLUCOSE; HOSPITALS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MEDICAL STAFF; MONITORING, PHYSIOLOGIC; PATIENTS; RESEARCH DESIGN; RISK MANAGEMENT;

EID: 79958000536     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500124     Document Type: Review

References (11)

1. International Organization for Standardization. Medical devices - application of risk management to medical devices. ISO 14971, 2nd ed. Geneva, Switzerland: IOS; 2007.
2. Clinical and Laboratory Standards Institute. Risk management techniques to identify and control laboratory error sources; approved guideline. EP18-A2, 2nd ed. Wayne, PA: CLSI; 2009.
3. Klonoff DC, Perz JF. Assisted monitoring of blood glucose: special safety needs for a new paradigm in testing glucose. J Diabetes Sci Technol. 2010;4(5):1027-31.
4. Ginsberg BH. We need tighter regulatory standards for blood glucose monitoring, but they should be for accuracy disclosure. J Diabetes Sci Technol. 2010:4(5):1265-8.
5. Medicines and Healthcare Products Regulatory Agency, U.K. Department of Health. Medical device alert. MDA/2007/058 - Point of care and home-use blood glucose meters: Roche Accu-Chek and Glucotrend; Abbott Diabetes Care FreeStyle. July 19, 2007. Available from: www.mhra.gov.uk. Accessed August 2010.
6. U.S. Food and Drug Administration. FDA Public Health Notification: Potentially Fatal Errors with GDH-PQQ*Glucose Monitoring Technology. August 13, 2009. www.fda.gov. Accessed August 2010.
7. Thomas A, Sall S, Roberts C, Drayton M, Dubois J, Clampitt R. An evaluation of the analytical performance of a new generation hospital based glucose meter and an assessment of its clinical reliability in a neonatal care unit. Point of Care. 2009;8(2):68-73.
8. Holtzinger C, Szelag E, DuBois JA, Shirey TL, Presti S. Evaluation of a new POCT bedside glucose meter and strip with hematocrit and interference corrections. Point of Care. 2008;7(1):1-6.
9. Blank FSJ, Miller M, Nichols J, Smithline H, Crabbe G, Pekow P. Blood glucose measurement in patients with suspected diabetic ketoacidosis: a comparison of Abbott Medisense PCx point-of-care meter values to reference laboratory values. J Emerg Nurs 2009;35(2):93-6.
10. Centers for Disease Control and Prevention. Infection prevention during blood glucose monitoring and insulin administration. CDC: Atlanta, GA. Available from: http://www.cdc.gov/injectionsafety/blood-glucose-monitoring. html. Accessed September 2010.
11. Nichols JH, Bartholomew C, Brunton M, Cintron C, Elliott S, McGirr J, Morsi D, Scott S, Seipel J, Sinha D. Reducing medical errors through barcoding at the point of care. Clin Leadersh Manag Rev. 2004;18(6):328-34.